Navigation Links
Advance Research Associates Joins DATATRAK's CRO Connect Program(TM)
Date:7/20/2009

CLEVELAND, July 20 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. a technology and services company focused on global eClinical solutions for the clinical trials industry, announced today that Advance Research Associates (ARA) has become the newest member of the DATATRAK CRO Connect Program(TM). ARA will utilize DATATRAK eClinical(TM) to capitalize on its Data Management functionality to more efficiently serve its paper and EDC clients.

"We look forward to a long and successful partnership with DATATRAK, delivering the highest quality of services and solutions to our clients," stated Peter Shabe, CEO of Advance Research Associates.

"We welcome ARA to a growing list of new CRO Connect partners," said Laurence Birch, DATATRAK's CEO. "ARA is known for it Data Management and Biostats expertise, two areas in which DATATRAK eClinical excels in adding value. We are excited to support our new partner as ARA expands its service offering."

DATATRAK's CRO Connect Program is a collaborative initiative with CROs that offers the benefits of our comprehensive DATATRAK eClinical(TM) solution through an innovative Enterprise Transfer program. This program allows CROs to package their services around our eClinical(TM) platform in order to gain efficiencies and increased market share. The CRO Connect Program's flexible pricing and specialized consulting and professional services provides participants with the tools necessary to realize new growth opportunities.

About ARA.

Founded in 1996, Advance Research Associates with more than 75 years of collective practical clinical research experience has become a trusted clinical research partner to the pharmaceutical, biotech, and medical device industries. In the years since its inception, ARA has provided a spectrum of innovative solutions and lent its expertise across a wide range of projects. While these customized solutions are always based entirely on client need, the success of any project hinges on the strength of the personal relationship developed between client and partner through daily communication. ARA's collaborative management philosophy supports extensive interaction, resulting in clients consistently achieving their highest objectives. For more information on ARA, visit www.araonline.net.

About DATATRAK International, Inc.

DATATRAK International, Inc. is a worldwide technology company focused on the provision of multi-component eClinical solutions and related services for the clinical trials industry. The Company delivers a complete portfolio of software products that were created in order to accelerate clinical research data from investigative sites to clinical trial sponsors and ultimately the FDA, faster and more efficiently than manual methods or loosely integrated technologies. DATATRAK's eClinical(TM) software suite can be deployed worldwide through an ASP offering or in a licensed Enterprise Transfer model that fully empowers its clients. The DATATRAK software suite and its earlier versions have successfully supported hundreds of international clinical trials involving thousands of clinical research sites and encompassing tens of thousands of patients in 59 countries. DATATRAK International, Inc.'s product suite has been utilized in some aspect of the clinical development of 16 drugs and one medical device that have received regulatory approval from either the United States Food and Drug Administration or counterpart European bodies. DATATRAK International, Inc. has offices located in Cleveland, Ohio, and Bryan, Texas. Visit the DATATRAK International, Inc. web site at www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors (including those specified below) which are difficult to predict and, in many instances, are beyond the control of the Company. Factors that may cause actual results to differ materially from those in the forward-looking statements include the limited operating history on which the Company's performance can be evaluated; the ability of the Company to continue to enhance its software products to meet customer and market needs; fluctuations in the Company's quarterly results; the viability of the Company's business strategy and its early stage of development; the timing of clinical trial sponsor decisions to conduct new clinical trials or cancel or delay ongoing trials; the Company's dependence on major customers; government regulation associated with clinical trials and the approval of new drugs; the ability of the Company to compete in the emerging EDC market; losses that potentially could be incurred from breaches of contracts or loss of customer data; the inability to protect intellectual property rights or the infringement upon other's intellectual property rights; the Company's success in integrating its acquisition's operations into its own operations and the costs associated with maintaining and/or developing two product suites; and general economic conditions such as the rate of employment, inflation, interest rates and the condition of capital markets. This list of factors is not all-inclusive. In addition, the Company's success depends on the outcome of various strategic initiatives it has undertaken, all of which are based on assumptions made by the Company concerning trends in the clinical research market and the health care industry. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE DATATRAK International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. National Hospice and Palliative Care Organizations Caring Connections and Google Health Offer New Way to Access Advance Directives Online
2. Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding DOXIL(R) for Treatment of Advanced Breast Cancer
3. Bayer HealthCare Awards $2.5 Million to Advance Hemophilia Research and Improve Patient Care
4. Marienkrankenhaus Hamburg Installs Visage(R) CS Enterprise Wide Advanced Visualization Solutions
5. Diabetes Advocates Call For National Strategy, Leadership to Reduce Diabetes and Advance Detection and Treatment
6. Advanced Bag Design for Cryopreservation: The New CryoMACS(R) Freezing Bag
7. University of Phoenix Expands Advanced Degree Programs; Adds Ph.D. in Nursing and Educational Specialist Degrees
8. TCS Healthcare Technologies to Offer Remote Hosting Options for Acuity Advanced Care(TM)
9. New Jersey Hospital Protects Patient Safety with Advanced Pharmacy Automation Solution
10. Advanced Heart Procedure Treats Growing Problem
11. Obama Administration Advances Long-Term Services and Supports in Health Care Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., ... analytics, today announced that it has been ranked #1 by ... Black Book™ Rankings 2017 User Survey. ZirMed was recognized ... for large hospitals and medical centers over 200 beds and ... Book,s healthcare technology user survey history. ...
(Date:9/12/2017)... Sept. 12, 2017  Consumer reviews on the independent review site ... the number one company for hearing aids, ranking it higher than ... brands. ... #1 by Consumers For Hearing Aids ... Hearing is an online store that provides high performance, state-of-the-art, German-engineered ...
Breaking Medicine Technology: